• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利：CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法，用中文像聊天一样搜索，搜遍4000万医学文献。AI智能推荐，让科研检索更轻松。

立即免费搜索

文件翻译

保留排版，准确专业，支持PDF/Word/PPT等文件格式，支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述，25分钟生成高质量综述，智能提取关键信息，辅助科研写作。

立即免费体验

Antidiabetic drugs and hypoglycaemia risk in patients with atrial fibrillation treated with non-vitamin K antagonist oral anticoagulants.

作者信息

Nabrdalik Katarzyna, Kwiendacz Hanna, Lip Gregory Y H

机构信息

Liverpool Centre for Cardiovascular Science at University of Liverpool, Liverpool John Moores University and Liverpool Heart and Chest Hospital, Liverpool, UK.

Department of Internal Medicine, Diabetology and Nephrology, Faculty of Medical Sciences in Zabrze, Medical University of Silesia, Katowice, Poland.

出版信息

Eur Heart J Cardiovasc Pharmacother. 2023 Jul 29;9(5):435-436. doi: 10.1093/ehjcvp/pvad042.

DOI:10.1093/ehjcvp/pvad042
PMID:37354547
Abstract
摘要

相似文献

1
Antidiabetic drugs and hypoglycaemia risk in patients with atrial fibrillation treated with non-vitamin K antagonist oral anticoagulants.非维生素K拮抗剂口服抗凝剂治疗的心房颤动患者中抗糖尿病药物与低血糖风险
Eur Heart J Cardiovasc Pharmacother. 2023 Jul 29;9(5):435-436. doi: 10.1093/ehjcvp/pvad042.
2
Risk of serious hypoglycaemia in patients with atrial fibrillation and diabetes concurrently taking antidiabetic drugs and oral anticoagulants: a nationwide cohort study.同时服用降糖药和口服抗凝药的房颤合并糖尿病患者发生严重低血糖的风险：一项全国性队列研究。
Eur Heart J Cardiovasc Pharmacother. 2023 Jul 29;9(5):427-434. doi: 10.1093/ehjcvp/pvad038.
3
Mortality risk in atrial fibrillation: the role of aspirin, vitamin K and non-vitamin K antagonists.心房颤动的死亡率：阿司匹林、维生素 K 和非维生素 K 拮抗剂的作用。
Int J Clin Pharm. 2019 Dec;41(6):1536-1544. doi: 10.1007/s11096-019-00916-1. Epub 2019 Oct 8.
4
Introduction of Non-Vitamin K Antagonist Anticoagulants Strongly Increased the Rate of Anticoagulation in Hospitalized Geriatric Patients with Atrial Fibrillation.非维生素K拮抗剂类抗凝剂的引入显著提高了老年房颤住院患者的抗凝率。
Drugs Aging. 2018 Sep;35(9):859-869. doi: 10.1007/s40266-018-0571-1.
5
Effectiveness, safety, and major adverse limb events in atrial fibrillation patients with concomitant diabetes mellitus treated with non-vitamin K antagonist oral anticoagulants.非维生素 K 拮抗剂口服抗凝剂治疗合并糖尿病的心房颤动患者的有效性、安全性和主要不良肢体事件。
Cardiovasc Diabetol. 2020 May 13;19(1):63. doi: 10.1186/s12933-020-01043-2.
6
[Diagnosis and assessment of hypoglycemia in patients with diabetes mellitus].[糖尿病患者低血糖的诊断与评估]
Rev Med Liege. 2014 Feb;69(2):110-5.
7
Risk of developing diabetes in patients with atrial fibrillation taking non-vitamin K antagonist oral anticoagulants or warfarin: A nationwide cohort study.服用非维生素 K 拮抗剂口服抗凝剂或华法林的心房颤动患者发生糖尿病的风险：一项全国性队列研究。
Diabetes Obes Metab. 2021 Feb;23(2):499-507. doi: 10.1111/dom.14243. Epub 2020 Nov 18.
8
Antithrombotic therapy use in patients with atrial fibrillation before the era of non-vitamin K antagonist oral anticoagulants: the Global Registry on Long-Term Oral Antithrombotic Treatment in Patients with Atrial Fibrillation (GLORIA-AF) Phase I cohort.非维生素K拮抗剂口服抗凝药时代之前心房颤动患者的抗栓治疗：心房颤动患者长期口服抗栓治疗全球注册研究（GLORIA-AF）第一阶段队列研究
Europace. 2016 Sep;18(9):1308-18. doi: 10.1093/europace/euw073. Epub 2016 Jun 21.
9
Patients with diabetes mellitus and atrial fibrillation treated with non-vitamin K antagonist oral anticoagulants: meta-analysis of eight outcomes in 58 634 patients across four randomized controlled trials.患有糖尿病和心房颤动的患者接受非维生素 K 拮抗剂口服抗凝剂治疗：四项随机对照试验中 58634 名患者的 8 项结局的荟萃分析。
Eur Heart J Cardiovasc Pharmacother. 2021 Apr 9;7(FI1):f40-f49. doi: 10.1093/ehjcvp/pvaa120.
10
Quality of life and patient satisfaction in patients with atrial fibrillation on stable vitamin K antagonist treatment or switched to a non-vitamin K antagonist oral anticoagulant during a 1-year follow-up: A PREFER in AF Registry substudy.在 1 年随访期间，接受稳定维生素 K 拮抗剂治疗或换用非维生素 K 拮抗剂口服抗凝剂的心房颤动患者的生活质量和患者满意度：AF 登记处的 PREFER 子研究。
Arch Cardiovasc Dis. 2018 Feb;111(2):74-84. doi: 10.1016/j.acvd.2017.04.007. Epub 2017 Sep 21.

引用本文的文献

1
Immunomodulatory Effect of Rivaroxaban Nanoparticles Alone and in Combination with Sitagliptin on Diabetic Rat Model.利伐沙班纳米颗粒单独及与西他列汀联合应用对糖尿病大鼠模型的免疫调节作用
Diseases. 2025 Mar 19;13(3):87. doi: 10.3390/diseases13030087.